These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8491188)

  • 1. A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes.
    Peeper DS; Parker LL; Ewen ME; Toebes M; Hall FL; Xu M; Zantema A; van der Eb AJ; Piwnica-Worms H
    EMBO J; 1993 May; 12(5):1947-54. PubMed ID: 8491188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin A recruits p33cdk2 to the cellular transcription factor DRTF1.
    Bandara LR; Adamczewski JP; Zamanian M; Poon RY; Hunt T; Thangue NB
    J Cell Sci Suppl; 1992; 16():77-85. PubMed ID: 1297652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the in vitro phosphorylation of HSSB-p34 and -p107 by cyclin-dependent kinases. Cyclin-substrate interactions dictate the efficiency of phosphorylation.
    Gibbs E; Pan ZQ; Niu H; Hurwitz J
    J Biol Chem; 1996 Sep; 271(37):22847-54. PubMed ID: 8798463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2.
    Poon RY; Yamashita K; Adamczewski JP; Hunt T; Shuttleworth J
    EMBO J; 1993 Aug; 12(8):3123-32. PubMed ID: 8393783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p107 and p130 associated cyclin A has altered substrate specificity.
    Hauser PJ; Agrawal D; Chu B; Pledger WJ
    J Biol Chem; 1997 Sep; 272(36):22954-9. PubMed ID: 9278460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
    Woo MS; Sánchez I; Dynlacht BD
    Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
    Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
    Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
    Zhu L; Harlow E; Dynlacht BD
    Genes Dev; 1995 Jul; 9(14):1740-52. PubMed ID: 7622038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
    Matsushime H; Ewen ME; Strom DK; Kato JY; Hanks SK; Roussel MF; Sherr CJ
    Cell; 1992 Oct; 71(2):323-34. PubMed ID: 1423597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
    Beijersbergen RL; Carlée L; Kerkhoven RM; Bernards R
    Genes Dev; 1995 Jun; 9(11):1340-53. PubMed ID: 7797074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Timchenko NA; Wilde M; Darlington GJ
    Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation.
    Li LJ; Naeve GS; Lee AS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3554-8. PubMed ID: 8475104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear localization of vertebrate cyclin A correlates with its ability to form complexes with cdk catalytic subunits.
    Maridor G; Gallant P; Golsteyn R; Nigg EA
    J Cell Sci; 1993 Oct; 106 ( Pt 2)():535-44. PubMed ID: 8282760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
    Lees E; Faha B; Dulic V; Reed SI; Harlow E
    Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2.
    Smith EJ; Nevins JR
    Mol Cell Biol; 1995 Jan; 15(1):338-44. PubMed ID: 7799940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between human cyclin A and adenovirus E1A-associated p107 protein.
    Faha B; Ewen ME; Tsai LH; Livingston DM; Harlow E
    Science; 1992 Jan; 255(5040):87-90. PubMed ID: 1532458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
    Pan ZQ; Amin A; Hurwitz J
    J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
    Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.